Who are Compound danshen dripping pills's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/compound-danshen-dripping-pills.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Compound danshen dripping pills — Competitive Intelligence Brief

Compound danshen dripping pills (Compound danshen dripping pills) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Traditional Chinese medicine preparation; antiplatelet/anticoagulant agent. Area: Cardiovascular.

marketed Traditional Chinese medicine preparation; antiplatelet/anticoagulant agent Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Compound danshen dripping pills (Compound danshen dripping pills) — Tasly Pharmaceuticals, Inc.. Compound danshen dripping pills improve blood circulation and reduce blood stasis by promoting vasodilation and inhibiting platelet aggregation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Compound danshen dripping pills TARGET	Compound danshen dripping pills	Tasly Pharmaceuticals, Inc.	marketed	Traditional Chinese medicine preparation; antiplatelet/anticoagulant agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Traditional Chinese medicine preparation; antiplatelet/anticoagulant agent class)

Tasly Pharmaceuticals, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Compound danshen dripping pills — Competitive Intelligence Brief. https://druglandscape.com/ci/compound-danshen-dripping-pills. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab